An Observational Study Assessing Changes in Health and Functional Status in Patients with Chronic Obstructive Pulmonary Disease (COPD) During Therapy with Spiolto® Respimat® in Everyday Clinical Practice: The Greek ELLACTO Study-Reference-Cited by-同舟云学术

An Observational Study Assessing Changes in Health and Functional Status in Patients with Chronic Obstructive Pulmonary Disease (COPD) During Therapy with Spiolto® Respimat® in Everyday Clinical Practice: The Greek ELLACTO Study

Published:2021-05-03 Issue:2 Volume:7 Page:429-443
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Kosmas Epaminondas,Titopoulos Iraklis,Patentalakis Georgios,Nikas Nikos

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

https://link.springer.com/content/pdf/10.1007/s41030-021-00156-7.pdf

Reference32 articles.

1. Rhee CK, Yoshisue H, Lad R. Fixed-dose combinations of long-acting bronchodilators for the management of COPD: global and Asian perspectives. Adv Ther. 2019;36:495–519.

2. Gulart AA, Munari AB, De QAPA, et al. Does the COPD assessment test reflect functional status in patients with COPD? Chron Respir Dis. 2017;14:37–44.

3. Ferguson G, Karpel J, Bennett N, et al. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies. npj Prim Care Respir Med. 2017;27:7.

4. Tashkin DP, Ferguson GT. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease, http://www.goldcopd.org.

5. Global Initiative for Chronic Obstructive Lung Disease. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2017 REPORT Visit the GOLD website at www.goldcopd.org © 2017 Global Initiative for Chronic Obstructive Lung Disease, www.goldcopd.org.